We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands ...

Factor XI Program: This initiative aims to develop a safer anticoagulant using two antibodies targeting Factor XI, leveraging genetic data for improved safety profiles. Regeneron’s acquisition ...

These winning initiatives demonstrate ... advanced business process management, and AI-driven intelligent search capabilities. By leveraging Regeneron's Operational Data Lake along with Appian's ...

FusionLayer, a leading innovator in cloud infrastructure solutions, proudly announces its membership in the Open Programmable Infrastructure (OPI) Project, fostering an open ecosystem for ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...

Slovakia's COVID-19 vaccine sceptic prime minister said on Monday that his country would challenge the adoption of a ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher Boerner.

Erik Wexler stepped into the top leadership role at 51-hospital Providence at a “tumultuous” time in healthcare, as he ...

Bay Area News Group: Live Organ Donations Are Growing In The U.S., California And Bay Area, But So Is The Need Since 2014, more than 500,000 people in the U.S. have donated organs, 200,000 of ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

These initiatives are projected to generate more ... America continues to dominate the artificial intelligence (AI) frontier, fueled by massive private investments. Leading the way is the $500 ...